{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "increases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "pubchem:681",
      "entity_text" : "dopamine",
      "entity_type" : "simple_chemical"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "pubchem:22880",
      "entity_text" : "NMDA",
      "entity_type" : "simple_chemical"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "The NMDA antagonist MK-801 increases both dopamine and glutamate efflux primarily in the forebrain regions [XREF_BIBR, XREF_BIBR] and induces the gene expres-sion of c-Fos through MK-801-evoked glutamatergic neurotransmission and subsequent MAP kinase / AP-1 activation [XREF_BIBR].",
  "reading_complete" : "2020-07-28T13:35:16Z",
  "reader_type" : "machine",
  "reading_started" : "2020-07-28T13:29:15Z",
  "trigger" : "increases",
  "evidence" : [ "NMDA antagonist MK-801 increases both dopamine" ],
  "pmc_id" : "4475761",
  "score" : 0
}